Nicholas Chirls
Partner @ Notation Capital
New York, United States
Nicholas Chirls is a pre-seed investor at Notation Capital in New York focused on Software and Information Technology. Nick is the Co-Founder and Partner at Notation. He previously ran seed investing at Betaworks. He attended the Hong Kong University of Science and Technology.
- Total investments:
- 53
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Nicholas Chirls invests in
Stages Nicholas Chirls invests in
Countries Nicholas Chirls invests in
Investment Focus
Industry
- Software 12 (23%)
- Information Technology 5 (9%)
- Health Care 4 (8%)
- Medical 3 (6%)
- Payments 3 (6%)
Stage
- Pre-Seed 24 (45%)
- Seed 23 (43%)
- Funding Round 3 (6%)
- Angel 1 (2%)
- Series A 1 (2%)
Country
- United States 40 (75%)
- Canada 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NOAT
|
We create tools that kill smoking. | $7M / Seed / Jan 01, 2025 | |
|
Spyglass
|
Simple, secure access management for data teams. | Pre-Seed / May 23, 2023 | |
|
Merkle
|
Cashback & rewards on every Ethereum transaction | Seed / Mar 20, 2023 | |
Cubist
|
Cubist brings modern software engineering practices and first-class security to web3 builders. Cubist’s toolkit makes it safe and easy to build, test and deploy multi-chain and cross-chain dapps in automated pipelines that handle keys and sequencing. | $7M / Seed / Mar 09, 2023 | |
Amplify Data
|
Amplify lets you unlock the full potential of your data by helping you create, maintain, and distribute your Data Products.Our customers are using Amplify's platform to offload the last-mile of data delivery, collaborate with customers/partners, and even monetize their data.Amplify is a rapidly growing Seed-stage company founded bydata and startup leaders and backed by premier investors. | $3.5M / Pre-Seed / Feb 01, 2023 | |
|
Density
|
Modern collaborative software for DJs | Pre-Seed / Dec 07, 2022 | |
Wayfinder Biosciences
|
Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting smallmolecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA. | $3.6M / Seed / Oct 17, 2022 | |
Loam
|
Loam develops an AI-enabled project developer assistant that develops and tests carbon and environmental contribution projects. It simplifies and accelerates the on-ramp to using AI to create insights, execute mission-critical functions, and drive strategic decisions. | Seed / Sep 21, 2022 | |
axodotdev
|
The devtool company for devtool companies. | Pre-Seed / Aug 10, 2022 | |
|
Shippy
|
FinOps command center for modern shipping operations | Pre-Seed / Jul 27, 2022 | |
| See all 53 investments → | |||
Co-Investors
About Notation Capital
Notation Capital is a pre-seed venture capital firm that work with technical founding teams. Notation Capital focus on early-stage technical teams, often pre-market or even pre-product, primarily in New York, and provide capital and support to help go-to-market and scale the company.
Notation Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Nicholas Chirls
Partner
|
|||
Alex Lines
Founder & Partner
|
|||
Jake Levine
Part Time Partner
|
|||
Mackenzie Regent
Fractional COO
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Nicholas Chirls invest in?
Nicholas Chirls invests primarily in Software, Information Technology and Health Care startups, most often at Pre-Seed and Seed stage. Most of the 53 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nicholas Chirls last invest?
The most recent investment recorded for Nicholas Chirls closed in Jan 2025. Shizune tracks 53 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
